Correlation Between Takeda Pharmaceutical and Telo Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and Telo Genomics Corp, you can compare the effects of market volatilities on Takeda Pharmaceutical and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Telo Genomics.

Diversification Opportunities for Takeda Pharmaceutical and Telo Genomics

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Takeda and Telo is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Telo Genomics go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Telo Genomics

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to generate 35.57 times less return on investment than Telo Genomics. But when comparing it to its historical volatility, Takeda Pharmaceutical is 40.63 times less risky than Telo Genomics. It trades about 0.18 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  3.65  in Telo Genomics Corp on August 26, 2024 and sell it today you would lose (0.15) from holding Telo Genomics Corp or give up 4.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.91%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  Telo Genomics Corp

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Telo Genomics Corp 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical and Telo Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and Telo Genomics

The main advantage of trading using opposite Takeda Pharmaceutical and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.
The idea behind Takeda Pharmaceutical and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal